Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30K Sell
113
-23
-17% -$6.08K ﹤0.01% 146
2026
Q1
$34K Buy
136
+5
+4% +$1.21K ﹤0.01% 140
2025
Q4
$28K Buy
131
+73
+126% +$15K ﹤0.01% 149
2025
Q3
$12K Buy
+58
New +$11.4K ﹤0.01% 191

Other funds holding WAB

Clal Insurance's WAB Position: Q2 2026 in Review

Clal Insurance reduced its Wabtec (WAB) stake by 17% in Q2 2026, selling an estimated $6.08K and leaving 113 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #146.

Clal Insurance first reported a position in WAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $34K in Q1 2026. 1,186 funds tracked by Wall St. Rank hold WAB as of Q2 2026.

  • Clal Insurance held 113 shares of Wabtec worth $30K as of Q2 2026.
  • Clal Insurance sold 23 Wabtec shares in Q2 2026, an estimated $6.08K.
  • Wabtec made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #146 holding.
  • Clal Insurance first reported a position in Wabtec in Q3 2025 and has held it in 4 quarters since.
  • Clal Insurance's Wabtec position peaked at $34K in Q1 2026.
  • 1,186 funds tracked by Wall St. Rank held Wabtec as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.